NURESCA Trademark

Trademark Overview


On Monday, April 16, 2018, a trademark application was filed for NURESCA with the United States Patent and Trademark Office. The USPTO has given the NURESCA trademark a serial number of 87878274. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 11, 2021. This trademark is owned by Pfizer Inc.. The NURESCA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
nuresca

General Information


Serial Number87878274
Word MarkNURESCA
Filing DateMonday, April 16, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 10, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 23, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, October 12, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 11, 2021ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 16, 2021EXTENSION 5 GRANTED
Monday, February 1, 2021EXTENSION 5 FILED
Tuesday, February 16, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 1, 2021TEAS EXTENSION RECEIVED
Thursday, August 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 4, 2020EXTENSION 4 GRANTED
Tuesday, August 4, 2020EXTENSION 4 FILED
Tuesday, August 4, 2020TEAS EXTENSION RECEIVED
Wednesday, February 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 3, 2020EXTENSION 3 GRANTED
Monday, February 3, 2020EXTENSION 3 FILED
Monday, February 3, 2020TEAS EXTENSION RECEIVED
Thursday, August 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2019EXTENSION 2 GRANTED
Tuesday, August 13, 2019EXTENSION 2 FILED
Tuesday, August 13, 2019TEAS EXTENSION RECEIVED
Tuesday, February 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 15, 2019EXTENSION 1 GRANTED
Friday, February 15, 2019EXTENSION 1 FILED
Friday, February 15, 2019TEAS EXTENSION RECEIVED
Tuesday, September 4, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 10, 2018PUBLISHED FOR OPPOSITION
Wednesday, June 20, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 30, 2018ASSIGNED TO EXAMINER
Monday, April 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 19, 2018NEW APPLICATION ENTERED IN TRAM